Literature DB >> 8886058

Alpha-blockade: monotherapy for hypertension and benign prostatic hyperplasia.

S A Kaplan1, N M Kaplan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8886058     DOI： 10.1016/S0090-4295(96)00242-7

Source DB:  PubMed          Journal:  Urology        ISSN： 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  7 in total

Review 1.  Benign prostatic hyperplasia.

Authors:  M J Barry; C G Roehrborn
Journal:  BMJ       Date:  2001-11-03

2.  Update on the american urological association guidelines for the treatment of benign prostatic hyperplasia.

Authors:  Steven A Kaplan
Journal:  Rev Urol       Date:  2006

3.  AUA Guidelines and Their Impact on the Management of BPH: An Update.

Authors:  Steven A Kaplan
Journal:  Rev Urol       Date:  2004

4.  alpha-Blocker Therapy: Current Update.

Authors:  Steven A Kaplan
Journal:  Rev Urol       Date:  2005

Review 5.  Benign prostatic hyperplasia and male lower urinary tract symptoms (LUTS).

Authors:  Tom McNicholas; Roger Kirby
Journal:  BMJ Clin Evid       Date:  2011-08-26

Review 6.  Treatment of benign prostatic hyperplasia in hypertensive men.

Authors:  William B White; Timothy Moon
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-04       Impact factor: 3.738

7.  Efficacy of amlodipine besylate and Valsartan for the treatment of mild to moderate hypertension.

Authors:  Xiao-Ou Wang; Wen Tian
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.